BG108339A - Лечение на деменция и дегенеративни разстройства с междинни дози lhrh-антагонисти - Google Patents

Лечение на деменция и дегенеративни разстройства с междинни дози lhrh-антагонисти Download PDF

Info

Publication number
BG108339A
BG108339A BG108339A BG10833903A BG108339A BG 108339 A BG108339 A BG 108339A BG 108339 A BG108339 A BG 108339A BG 10833903 A BG10833903 A BG 10833903A BG 108339 A BG108339 A BG 108339A
Authority
BG
Bulgaria
Prior art keywords
use according
methyl
lhrh antagonist
monthly
treatment
Prior art date
Application number
BG108339A
Other languages
Bulgarian (bg)
English (en)
Inventor
Juergen Engel
Rainer Voegeli
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Publication of BG108339A publication Critical patent/BG108339A/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
BG108339A 2001-04-30 2003-11-10 Лечение на деменция и дегенеративни разстройства с междинни дози lhrh-антагонисти BG108339A (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28743401P 2001-04-30 2001-04-30

Publications (1)

Publication Number Publication Date
BG108339A true BG108339A (bg) 2004-11-30

Family

ID=23102886

Family Applications (1)

Application Number Title Priority Date Filing Date
BG108339A BG108339A (bg) 2001-04-30 2003-11-10 Лечение на деменция и дегенеративни разстройства с междинни дози lhrh-антагонисти

Country Status (28)

Country Link
US (1) US7288517B2 (fr)
EP (1) EP1392348B1 (fr)
JP (1) JP2004529207A (fr)
KR (1) KR20040000446A (fr)
CN (1) CN1317030C (fr)
AT (1) ATE400287T1 (fr)
AU (1) AU2002310788B2 (fr)
BG (1) BG108339A (fr)
BR (1) BR0209290A (fr)
CA (1) CA2444876A1 (fr)
CZ (1) CZ20033167A3 (fr)
DE (1) DE60227507D1 (fr)
DK (1) DK1392348T3 (fr)
ES (1) ES2307760T3 (fr)
HK (1) HK1072000A1 (fr)
HU (1) HUP0400067A2 (fr)
IL (1) IL156777A0 (fr)
MX (1) MXPA03008666A (fr)
NO (1) NO20034322L (fr)
NZ (1) NZ544417A (fr)
PL (1) PL362319A1 (fr)
PT (1) PT1392348E (fr)
RU (1) RU2319501C2 (fr)
SI (1) SI1392348T1 (fr)
SK (1) SK14512003A3 (fr)
UA (1) UA80679C2 (fr)
WO (1) WO2002102401A1 (fr)
ZA (1) ZA200305326B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
US20020077327A1 (en) * 1999-09-23 2002-06-20 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
KR100748294B1 (ko) * 2000-07-05 2007-08-09 아스텔라스세이야쿠 가부시키가이샤 프로판-1,3-디온 유도체
DE10137174A1 (de) * 2001-07-31 2003-02-13 Zentaris Ag Verwendung von LHRH-Antagonisten in nichtkastrierenden Dosen zur Verbesserung der T-Zellen-vermittelten Immunität
US7709519B2 (en) * 2004-06-04 2010-05-04 Astellas Pharma Inc. Benzimidazolylidene propane-1,3 dione derivative or salt thereof
US20080171736A1 (en) * 2004-12-23 2008-07-17 Gregory Christopher W Treatment of Alzheimer's Disease and Mild Cognitive impairment using GnRH-I analogs and one or more of acetylcholinesterase inhibitors and NMDA receptor antagonists
CN101087618A (zh) * 2004-12-23 2007-12-12 航行药物公司 醋酸亮丙瑞林和乙酰胆碱酯酶抑制剂或nmda受体抑制剂在阿尔茨海默氏病治疗中的应用
KR101046039B1 (ko) * 2005-03-31 2011-07-01 아스텔라스세이야쿠 가부시키가이샤 프로판-1,3-디온 유도체 또는 그의 염
JP5406030B2 (ja) 2006-10-21 2014-02-05 アボット ゲーエムベーハー ウント カンパニー カーゲー 複素環化合物およびそれらのグリコーゲンシンターゼキナーゼ３阻害薬としての使用
JP2010538994A (ja) * 2007-09-11 2010-12-16 モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト 例えば肺炎連鎖球菌感染症を治療するためのｂｆｇｆ１−２４および任意での（ａｒｇ８）バソプレシンの使用
EP2185180A1 (fr) * 2007-09-11 2010-05-19 Mondobiotech Laboratories AG Big gastrine-i en tant qu'agent thérapeutique
EP2095818A1 (fr) * 2008-02-29 2009-09-02 AEterna Zentaris GmbH Utilisation d'antagonistes LHRH dans des doses n'impliquant pas de castration
WO2009145690A1 (fr) * 2008-05-29 2009-12-03 Isr Immune System Regulation Ab Procédé et moyens de traitement d'une maladie virale, en particulier le vih/sida
EP2621914B1 (fr) 2010-09-27 2016-12-28 Abbott GmbH & Co. KG Composés hétérocycliques et leur utilisation en tant qu'inhibiteurs de la glycogène synthase kinase-3
US9090592B2 (en) 2010-12-30 2015-07-28 AbbVie Deutschland GmbH & Co. KG Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
EP3560555A1 (fr) * 2018-04-26 2019-10-30 LifeArc Composition pour traiter une ou plusieurs maladies liées aux strogènes

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3135743A (en) 1960-06-29 1964-06-02 Sterling Drug Inc Steroido[2. 3-d]isoxazoles and preparation thereof
JP2000511532A (ja) 1996-05-20 2000-09-05 メルク エンド カンパニー インコーポレーテッド 性腺刺激ホルモン放出ホルモンのアンタゴニスト
DE19911771B4 (de) 1999-03-17 2006-03-30 Zentaris Gmbh LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung
AU767440B2 (en) 1999-05-14 2003-11-13 Neurocrine Biosciences, Inc. Imidazo- and pyrrolo(1,2-A)pyrimid-4-ones as gonadotropin-releasing hormone receptor antagonists
CA2309395A1 (fr) 1999-06-04 2000-12-04 Richard Lloyd Bowen Methodes de prevention et de traitement de la maladie d'alzheimer
CA2386942A1 (fr) * 1999-10-15 2001-04-26 Neurocrine Biosciences, Inc. Antagonistes du recepteur de l'hormone liberant de la gonadotropine et methodes d'utilisation
EP1393747A4 (fr) 2000-04-13 2004-03-03 Takeda Chemical Industries Ltd Agents preventifs/remedes pour la maladie d'alzheimer
KR100748294B1 (ko) 2000-07-05 2007-08-09 아스텔라스세이야쿠 가부시키가이샤 프로판-1,3-디온 유도체

Also Published As

Publication number Publication date
MXPA03008666A (es) 2004-10-15
RU2319501C2 (ru) 2008-03-20
CN1575185A (zh) 2005-02-02
EP1392348A1 (fr) 2004-03-03
AU2002310788B2 (en) 2007-04-05
NZ544417A (en) 2008-03-28
KR20040000446A (ko) 2004-01-03
DK1392348T3 (da) 2008-09-29
IL156777A0 (en) 2004-02-08
SK14512003A3 (sk) 2004-08-03
ZA200305326B (en) 2003-07-30
NO20034322D0 (no) 2003-09-26
CN1317030C (zh) 2007-05-23
ES2307760T3 (es) 2008-12-01
PT1392348E (pt) 2008-09-09
PL362319A1 (en) 2004-10-18
JP2004529207A (ja) 2004-09-24
EP1392348B1 (fr) 2008-07-09
BR0209290A (pt) 2004-07-13
CZ20033167A3 (cs) 2004-08-18
UA80679C2 (en) 2007-10-25
US20020177556A1 (en) 2002-11-28
RU2003134949A (ru) 2005-02-10
HUP0400067A2 (hu) 2004-04-28
HK1072000A1 (en) 2005-08-12
US7288517B2 (en) 2007-10-30
SI1392348T1 (sl) 2008-12-31
ATE400287T1 (de) 2008-07-15
NO20034322L (no) 2003-09-26
CA2444876A1 (fr) 2002-12-27
WO2002102401A1 (fr) 2002-12-27
DE60227507D1 (de) 2008-08-21

Similar Documents

Publication Publication Date Title
BG108339A (bg) Лечение на деменция и дегенеративни разстройства с междинни дози lhrh-антагонисти
EP1663236B1 (fr) Combinaison a base de n-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulfonamide et d'un bisphosphonate
JP2020040971A (ja) 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
AU2002310788A1 (en) Treatment of dementia and neurodegenerative diseases with intermediate doses of LHRH antagonists
JP2006502969A (ja) 内因性性腺刺激ホルモン産生の増強
US20090054319A1 (en) Methods and Compositions for the Treatment of Hypertension and Gastrointestinal Disorders
DE60314896T2 (de) 5-ht 1b/1d rezeptor agonisten zur behandlung von kopfschmerz der aus der verabreichung von endothelin rezeptor antagonisten resultiert
DE69927705T2 (de) Verwendung von acetylcholinesterase inhibitoren zur modulierung der hypothalamus-hypophysen-gonadenachse
US11872219B2 (en) Compositions and methods for intrathecal administration of MCOPPB for pain relief
CN1501802A (zh) 芳基乙烯磺酰胺衍生物的新用途
EP1610771B1 (fr) Utilisation d'un antagoniste de l'adrenorecepteur alpha-2 pour le traitement de l'epilepsie
US20040157772A1 (en) Use of a gatran for the manufacture of a medicament of the treatment of pulmonary fibrosis
EP0998923A1 (fr) Utilisation des agonistes du recepteur 5-HT7 pour le traitement ou la prophylaxe des ischémies
AU2002305989A1 (en) The use of a gatran for the manufacture of a medicament for the treatment of pulmonary fibrosis
FR2919803A1 (fr) Utilisation d'un antagoniste non peptidique du recepteur b1 pour la preparation de medicaments utiles pour le traitement de l'obesite et des pathologies liees a l'obesite ou au diabete